商务合作
动脉网APP
可切换为仅中文
CHICAGO and ST. PAUL, Minn., May 08, 2024 (GLOBE NEWSWIRE) -- Granite Creek Capital Partners, a Chicago-based private investment firm, grows its footprint in the animal health market through its recent funding of Veterinary Pharmaceutical Solutions’ (“VPS”) acquisition of Diamond Animal Health (“Diamond”).
芝加哥和明尼苏达州圣保罗,2024年5月8日(环球通讯社)--Granite Creek Capital Partners是一家总部位于芝加哥的私人投资公司,通过最近对兽医药物解决方案(“VPS”)收购钻石动物健康(“Diamond”)的资助,扩大了其在动物健康市场的足迹。
Granite Creek supported VPS’ acquisition of Diamond through a follow-on investment from its FlexCap II fund, executing on the firm’s continued pursuit of animal health investment opportunities. Granite Creek purchased VPS, a licensed animal compounding pharmacy focused on supporting the veterinary community in 2020, and has actively supported the company in driving growth through strategic investments in human capital, new product development, and facility expansion.
Granite Creek通过其FlexCap II基金的后续投资支持VPS收购Diamond,这是该公司继续寻求动物健康投资机会的结果。Granite Creek于2020年收购了VPS,这是一家获得许可的动物复合药店,专注于支持兽医界,并通过人力资本、新产品开发和设施扩建的战略投资,积极支持公司推动增长。
The Diamond acquisition represents the first of many planned platform additions as the company looks to expand its capabilities and market reach. Granite Creek worked closely with VPS leadership through the acquisition of Diamond, a contract manufacturer and researcher of animal vaccines and pharmaceuticals that are utilized by veterinarians of production and companion animals.
钻石收购是该公司计划增加的众多平台中的第一个,因为该公司希望扩大其能力和市场范围。Granite Creek通过收购Diamond与VPS领导层密切合作,Diamond是一家合同制造商和动物疫苗和药物的研究人员,生产兽医和伴侣动物使用这些疫苗和药物。
The combined business provides a full suite of solutions to meet veterinarians' needs while remaining a valuable partner to other pharmaceutical and biological companies working with Diamond to manufacture their products. Furthermore, VPS and Diamond’s combined pharmacy, chemistry, quality, and regulatory capabilities uniquely position the company for rapid innovation.
合并后的业务提供了一整套解决方案,以满足兽医的需求,同时仍然是与钻石合作生产产品的其他制药和生物公司的宝贵合作伙伴。此外,VPS和Diamond的制药、化学、质量和监管能力相结合,为公司的快速创新奠定了独特的地位。
“We view production animal health as an attractive end-market. Innovative companies in this sector are critical in supporting stable protein sources for consumers while ensuring efficiency and safety in the supply chain,” said Mike Ray, Operating Partner at Granite.
Granite的运营合伙人迈克·雷(MikeRay)表示:“我们将动物健康生产视为一个有吸引力的终端市场。这一领域的创新公司对于为消费者提供稳定的蛋白质来源至关重要,同时确保供应链的效率和安全。”。
最近内容 查看更多
Dyne Therapeutics将于美国东部时间明天5月20日上午8:00举办虚拟投资者活动,审查ACHIEVE和DELIVER试验的新临床数据
4 小时前
NASDAQ:NARI:Kessler Topaz Meltzer&Check,LLP通知投资者对Inari Medical,股份有限公司提起的证券集体诉讼
1 天前
Intercept提供了新数据,证明OCA-苯扎贝特联合治疗对2024年消化道疾病周治疗六个月后ALP和代谢结果的影响
1 天前
相关机构查看更多
Granite Creek
私募股权资本投资商
产业链接查看更多
所属赛道